Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
61.66
-2.77 (-4.30%)
Nov 17, 2026, 3:00 PM CST

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 107.22M CNY in the quarter ending September 30, 2026, with 3.02% growth. This brings the company's total for the last twelve months to 472.32M, up 9.55% year-over-year. In the year 2025, Beijing Hotgen Biotech had annual revenue of 404.88M, down -20.58%. That makes Beijing Hotgen Biotech the 25,379th largest company in the world by revenue and 4,519th in China.

Revenue (ttm)
472.32M
Revenue Growth
+9.55%
P/S Ratio
11.51
Revenue / Employee
452.84K
Employees
1,043
Market Cap
5.44B

Revenue Chart

Revenue by Geography

  • China 373.50M 94.4%
  • Overseas 21.96M 5.6%
Fiscal year ended Dec 31, 2025 See the full Beijing Hotgen Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025404.88M-104.90M-20.58%
Dec 31, 2024509.78M-38.06M-6.95%
Dec 31, 2023547.84M-3.01B-84.60%
Dec 31, 20223.56B-1.81B-33.76%
Dec 31, 20215.37B4.86B945.54%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.